NGA NGUYEN: Open Payments
NPI 1245994532 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 19 payments from 9 companies in 2025. Trend: 2023 $160 · 2024 $340 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $150 |
| Phathom Pharmaceuticals, Inc. | 2 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Lilly USA, LLC | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Ardelyx, Inc. | 1 | $15 |
Products named: VOQUEZNA, LINZESS, CREON, REZDIFFRA, ENTYVIO, OMVOH, OCALIVA, GATTEX.
Industry payments across TX — which companies pay providers there.
